Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs–EBP interaction recover NAFLD through enhancing mitochondrial function in mice-Reference-Cited by-同舟云学术

Synergistic activation of AMPK by AdipoR1/2 agonist and inhibitor of EDPs–EBP interaction recover NAFLD through enhancing mitochondrial function in mice

Published:2023-02 Issue:2 Volume:13 Page:542-558
ISSN:2211-3835
Container-title:Acta Pharmaceutica Sinica B
language:en
Short-container-title:Acta Pharmaceutica Sinica B

Author:

Song Nazi,Xu Hongjiao,Wu Shuohan,Luo Suijia,Xu Jingyao,Zhao Qian,Wang Rui,Jiang Xianxing

Publisher

Elsevier BV

Subject

General Pharmacology, Toxicology and Pharmaceutics

Reference50 articles.

1. From NAFLD to NASH to cirrhosis—new insights into disease mechanisms;Wree;Nat Rev Gastroenterol Hepatol,2013

2. Mechanisms of NAFLD development and therapeutic strategies;Friedman;Nat Med,2018

3. Therapeutic potential of PPARγ natural agonists in liver diseases;Wu;J Cell Mol Med,2020

4. Nutrient-sensing nuclear receptors PPARα and FXR control liver energy balance;Preidis;J Clin Invest,2017

5. Global epidemiology of NAFLD-related HCC: trends, predictions, risk factors and prevention;Huang;Nat Rev Gastroenterol Hepatol,2021

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Schisanhenol ameliorates non-alcoholic fatty liver disease via inhibiting miR-802 activation of AMPK-mediated modulation of hepatic lipid metabolism;Acta Pharmaceutica Sinica B;2024-09

2. Mitophagy in fibrotic diseases: molecular mechanisms and therapeutic applications;Frontiers in Physiology;2024-08-09

3. Liver Cell Mitophagy in Metabolic Dysfunction-Associated Steatotic Liver Disease and Liver Fibrosis;Antioxidants;2024-06-15

4. Design and Synthesis of Novel Ultralong-Acting Peptides as EDP-EBP Interaction Inhibitors for Pulmonary Fibrosis Treatment;Journal of Medicinal Chemistry;2024-04-08

5. Drug targets regulate systemic metabolism and provide new horizons to treat nonalcoholic steatohepatitis;Metabolism Open;2024-03